SINGLE-CENTER RETROSPECTIVE ANALYSIS OF THE EFFECT OF LUMACAFTOR/IVACAFTOR AND ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON BIOMARKERS OF LIVER DISEASE IN CYSTIC FIBROSIS

被引：0
|
作者：
Fuchs, Yonathan [1 ]
Levitte, Steven [2 ]
Wise, Russell [2 ]
Sellers, Zachary [2 ]
机构：
[1] Yale Univ, New Haven, CT 06520 USA
[2] Stanford Univ, Stanford, CA 94305 USA
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1982
引用
收藏
页码：1178A / 1179A
页数：2
相关论文
共 50 条
  • [1] SINGLE-CENTER EXPERIENCE OF PEDIATRIC CYSTIC FIBROSIS PATIENTS STARTED ON ELEXACAFTOR/TEZACAFTOR/IVACAFTOR
    Allan, K.
    Carr, P.
    Denhard, M.
    Mogayzel, P. J.
    Pan, A.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S224 - S224
  • [2] Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) for Cystic Fibrosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1589): : 5 - 7
  • [3] Cystic Fibrosis: Triple Therapy with Elexacaftor, Tezacaftor and Ivacaftor
    Lorenz, Judith
    PNEUMOLOGIE, 2022, 76 (03): : 153 - 153
  • [4] Tolerance of elexacaftor/tezacaftor/ivacaftor in Australians with cystic fibrosis
    Ruseckaite, Rasa
    Wark, Peter
    Pourghaderi, Ahmadreza
    Caruso, Marisa
    Ahern, Susannah
    RESPIROLOGY, 2024, 29 : 8 - 8
  • [5] Use of elexacaftor/tezacaftor/ivacaftor in liver transplant patients with cystic fibrosis
    McKinzie, Cameron J.
    Doligalski, Christina T.
    Lobritto, Steven J.
    Coakley, Raymond D.
    Gower, W. Adam
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (02) : 227 - 229
  • [6] Effects of elexacaftor/tezacaftor/ivacaftor on liver fibrosis markers in adults with cystic fibrosis
    Tewkesbury, Daniel H.
    Scott, Jennifer
    Barry, Peter J.
    Bright-Thomas, Rowland J.
    Hanley, Karen Piper
    Athwal, Varinder
    Jones, Andrew M.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (02) : 349 - 353
  • [7] EFFECTS OF ELEXACAFTOR/ TEZACAFTOR/ IVACAFTOR ON MARKERS OF LIVER FIBROSIS IN ADULTS WITH CYSTIC FIBROSIS
    Portolese, Olivia
    Bilodeau, Marc
    Castel, Helene
    Willems, Bernard E.
    Huard, Genevieve
    Vincent, Catherine
    Lavoie, Annick
    Hercun, Julian
    HEPATOLOGY, 2023, 78 : S638 - S639
  • [8] Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Advanced Cystic Fibrosis Lung Disease
    Djavid, Amir Reza
    Thompson, Alison E.
    Irace, Alexandria L.
    Gusman, Elen
    Altman, Kimberly
    DiMango, Emily A.
    Keating, Claire L.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (11) : 1924 - 1927
  • [9] Elexacaftor/Tezacaftor/Ivacaftor use in Pediatric Cystic Fibrosis Patients with Advanced Liver Disease
    Protich, Hannah E.
    Molleston, Jean P.
    Bozic, Molly
    Pettit, Rebecca S.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (06) : 1122 - 1128
  • [10] Therapeutic Drug Monitoring of Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis: Where Are We Now?
    Choong, Eva
    Sauty, Alain
    Koutsokera, Angela
    Blanchon, Sylvain
    Andre, Pascal
    Decosterd, Laurent
    PHARMACEUTICS, 2022, 14 (08)
12345